A gene variant near ATM is significantly associated with metformin treatment response in type 2 diabetes: a replication and meta-analysis of five cohorts

A gene variant near ATM is significantly associated with metformin treatment response in type 2 diabetes: a replication and meta-analysis of five cohorts

Zobrazit další vydání (1)

Podrobná bibliografie
Hlavní autoři:	van Leeuwen, N, Nijpels, G, Becker, M, Deshmukh, H, Zhou, K, Stricker, B, Uitterlinden, A, Hofman, A, van 't Riet, E, Palmer, C, Guigas, B, Slagboom, P, Durrington, P, Calle, R, Neil, A, Hitman, G, Livingstone, S, Colhoun, H, Holman, R, McCarthy, M, Dekker, J, 't Hart, L, Pearson, E
Médium:	Journal article
Vydáno:	2012

Podobné jednotky

A gene variant near ATM is significantly associated with metformin treatment response in type 2 diabetes: a replication and meta-analysis of five cohorts.
Autor: van Leeuwen, N, a další
Vydáno: (2012)

A gene variant near ATM is significantly associated with metformin treatment response in type 2 diabetes: a replication and meta-analysis of two Dutch and two UK cohorts
Autor: 't Hart, L, a další
Vydáno: (2011)

The role of ATM in response to metformin treatment and activation of AMPK.
Autor: Zhou, K, a další
Vydáno: (2012)

Rapid emergence of effect of atorvastatin on cardiovascular outcomes in the Collaborative Atorvastatin Diabetes Study (CARDS).
Autor: Colhoun, H, a další
Vydáno: (2005)

Effect of atorvastatin on stroke in the collaborative atorvastatin diabetes study (CARDS): Factors predictive of the risk of stroke
Autor: Newman, C, a další
Vydáno: (2005)

Baseline characteristics in the Collaborative AtoRvastatin Diabetes Study (CARDS) in patients with Type 2 diabetes.
Autor: Thomason, M, a další
Vydáno: (2004)

Stroke prediction and stroke prevention with atorvastatin in the Collaborative Atorvastatin Diabetes Study (CARDS).
Autor: Hitman, G, a další
Vydáno: (2007)

Effect of atorvastatin in patients 65 years of age with type 2 diabetes: Subgroup analysis from the collaborative atorvastatin diabetes study (CARDS)
Autor: DeMicco, D, a další
Vydáno: (2005)

Analysis of efficacy and safety in patients aged 65-75 years at randomization: Collaborative Atorvastatin Diabetes Study (CARDS).
Autor: Neil, H, a další
Vydáno: (2006)

Effect of atorvastatin on stroke in patients with type 2 diabetes: factors predicting the risk of stroke in the Collaborative Atorvastatin Diabetes Study (CARDS)
Autor: Hitman, G, a další
Vydáno: (2005)

Effects of atorvastatin on kidney outcomes and cardiovascular disease in patients with diabetes: an analysis from the Collaborative Atorvastatin Diabetes Study (CARDS).
Autor: Colhoun, H, a další
Vydáno: (2009)

Total soluble and endogenous secretory receptor for advanced glycation end products as predictive biomarkers of coronary heart disease risk in patients with type 2 diabetes: an analysis from the CARDS trial.
Autor: Colhoun, H, a další
Vydáno: (2011)

Cost-effectiveness of primary prevention of cardiovascular disease with atorvastatin in type 2 diabetes: results from the Collaborative Atorvastatin Diabetes Study (CARDS).
Autor: Raikou, M, a další
Vydáno: (2007)

Primary prevention of cardiovascular disease with atorvastatin in type 2 diabetes in the Collaborative Atorvastatin Diabetes Study (CARDS): multicentre randomised placebo-controlled trial.
Autor: Colhoun, H, a další
Vydáno: (2004)

Change in Lp-PLA2 With Risk Change on Statin Therapy in the Collaborative Atorvastatin Diabetes Study (CARDS)
Autor: Betteridge, D, a další
Vydáno: (2009)

Role of Mitochondria in the Mechanism(s) of Action of Metformin
Autor: Guillaume Vial, a další
Vydáno: (2019-05-01)

Heritability of variation in glycaemic response to metformin: a genome-wide complex trait analysis.
Autor: Zhou, K, a další
Vydáno: (2014)

Common variants near ATM are associated with glycemic response to metformin in type 2 diabetes.
Autor: Zhou, K, a další
Vydáno: (2011)

Common variants near ATM are associated with glycemic response to metformin in type 2 diabetes
Autor: Zhou, K, a další
Vydáno: (2011)

Erratum: Apolipoproteins, cardiovascular risk and statin response in type 2 diabetes: The Collaborative Atorvastatin Diabetes Study (CARDS)
Autor: Charlton-Menys, V, a další
Vydáno: (2009)

Design of the Collaborative AtoRvastatin Diabetes Study (CARDS) in patients with type 2 diabetes.
Autor: Colhoun, H, a další
Vydáno: (2002)

Apolipoproteins, cardiovascular risk and statin response in type 2 diabetes: the Collaborative Atorvastatin Diabetes Study (CARDS).
Autor: Charlton-Menys, V, a další
Vydáno: (2009)

Targets of statin therapy: LDL cholesterol, non-HDL cholesterol, and apolipoprotein B in type 2 diabetes in the Collaborative Atorvastatin Diabetes Study (CARDS).
Autor: Charlton-Menys, V, a další
Vydáno: (2009)

Heritability of variation in glycaemic response to metformin: A genome-wide complex trait analysis
Autor: Zhou, K, a další
Vydáno: (2014)

Cost-effectiveness of atorvastatin (10mg) in patients with type 2 diabetes without coronary heart disease: CARDS trial analysis and extrapolation
Autor: Raikou, M, a další
Vydáno: (2005)

The safety and tolerability of atorvastatin 10 mg in the Collaborative Atorvastatin Diabetes Study (CARDS).
Autor: Newman, C, a další
Vydáno: (2008)

Safety of atorvastatin in the collaborative AtoRvastatin diabetes study (CARDS)
Autor: Newman, C, a další
Vydáno: (2006)

C-reactive Protein and Amyloid A as Predictors of Cardiovascular Events in Type 2 Diabetes in CARDS
Autor: Charlton-Menys, V, a další
Vydáno: (2009)

Alterations in cellular energy metabolism associated with the antiproliferative effects of the ATM inhibitor KU-55933 and with metformin.
Autor: Mahvash Zakikhani, a další
Vydáno: (2012-01-01)

The effect of atorvastatin on serum lipids, lipoproteins and NMR spectroscopy defined lipoprotein subclasses in type 2 diabetic patients with ischaemic heart disease.
Autor: Soedamah-Muthu, S, a další
Vydáno: (2003)

Metformin and mortality. Reply to Lund SS [letter]
Autor: Stevens, R, a další
Vydáno: (2013)

Metformin and mortality. Reply to Lund SS [letter].
Autor: Stevens, R, a další
Vydáno: (2013)

The effect of atorvastatin therapy on tumour necrosis factor-α and vascular adhesion molecules in patients with type 2 diabetes mellitus with no prior history of coronary heart disease
Autor: Soedamah-Muthu, S, a další
Vydáno: (2011)

Metformin and risk of cardiovascular disease.
Autor: Turner, R, a další
Vydáno: (1999)

Risk of anaemia with long-term metformin use in a community setting
Autor: Donnelly, L, a další
Vydáno: (2017)

The sustained influence of metformin therapy on circulating GLP-1 levels in individuals with and without type 2 diabetes
Autor: Preiss, D, a další
Vydáno: (2016)

ANALISIS TERHADAP PERLINDUNGAN HUKUM BAGI NASABAH PENGGUNA ATM (SKIMMING KARTU ATM PADA MESIN ATM BANK X)
Autor: , Ronald Arthur Saiya, a další
Vydáno: (2014)

Identifying the Latitude and Longitude of ATMs in ATM Networks
Autor: Niloofar Haghjoo, a další
Vydáno: (2024-06-01)

The C Allele of ATM rs11212617 Associates With Higher Pathological Complete Remission Rate in Breast Cancer Patients Treated With Neoadjuvant Metformin
Autor: Elisabet Cuyàs, a další
Vydáno: (2019-03-01)

METFORMIN IN THE MANAGEMENT OF TYPE-2 DIABETES - REPLY
Autor: Holman, R, a další
Vydáno: (1989)